0001055726-21-000034.txt : 20210326 0001055726-21-000034.hdr.sgml : 20210326 20210326161007 ACCESSION NUMBER: 0001055726-21-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210325 FILED AS OF DATE: 20210326 DATE AS OF CHANGE: 20210326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shea Jacqueline Elizabeth CENTRAL INDEX KEY: 0001771498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 21777423 MAIL ADDRESS: STREET 1: C/O INOVIO PHARMACEUTICALS, INC. STREET 2: 660 W. GERMANTOWN PIKE, SUITE 110 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 4 1 wf-form4_161678939086989.xml FORM 4 X0306 4 2021-03-25 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001771498 Shea Jacqueline Elizabeth 660 W. GERMANTOWN PIKE PLYMOUTH MEETING PA 19462 0 1 0 0 Chief Operating Officer Common Stock 2021-03-25 4 M 0 16667 A 72084 D Common Stock 2021-03-25 4 F 0 7247 9.06 D 64837 D Common Stock 2021-03-26 4 S 0 4710 8.97 D 60127 D Restricted Stock Unit 2021-03-25 4 M 0 16667 0 D Common Stock 16667.0 16666 D Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares will vest on March 25, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. /s/ Jacqueline E. Shea 2021-03-26